Texas Biomedical Research Institute, San Antonio, TX, United States.
The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, United States.
Front Cell Infect Microbiol. 2024 Jun 28;14:1408245. doi: 10.3389/fcimb.2024.1408245. eCollection 2024.
While simian immunodeficiency virus (SIV) infection is non-pathogenic in naturally infected African nonhuman primate hosts, experimental or accidental infection in rhesus macaques often leads to AIDS. Baboons, widely distributed throughout Africa, do not naturally harbor SIV, and experimental infection of baboons with SIVmac results in transient low-level viral replication. Elucidation of mechanisms of natural immunity in baboons could uncover new targets of antiviral intervention. We tested the hypothesis that an SIVmac adapted to replicate in baboon primary cells will gain the capacity to establish chronic infections . Here, we generated SIVmac variants in baboon cells through serial passage in PBMC from different donors (SIVbn-PBMC s1), in PBMC from the same donors (SIVbn-PBMC s2), or in isolated CD4 cells from the same donors used for series 2 (SIVbn-CD4). While SIVbn-PBMC s1 and SIVbn-CD4 demonstrated increased replication capacity, SIVbn-PBMC s2 did not. Pharmacological blockade of CCR5 revealed SIVbn-PBMC s1 could more efficiently use available CCR5 than SIVmac, a trait we hypothesize arose to circumvent receptor occupation by chemokines. Sequencing analysis showed that all three viruses accumulated different types of mutations, and that more non-synonymous mutations became fixed in SIVbn-PBMC s1 than SIVbn-PBMC s2 and SIVbn-CD4, supporting the notion of stronger fitness pressure in PBMC from different genetic backgrounds. Testing the individual contribution of several newly fixed SIV mutations suggested that is the additive effect of these mutations in SIVbn-PBMC s1 that contributed to its enhanced fitness, as recombinant single mutant viruses showed no difference in replication capacity over the parental SIVmac239 strain. The replicative capacity of SIVbn-PBMC passage 4 (P4) s1 was tested by infecting baboons intravenously with SIVbn-PBMC P4 s1 or SIVmac251. While animals infected with SIVmac251 showed the known pattern of transient low-level viremia, animals infected with SIVbn-PBMC P4 s1 had undetectable viremia or viral DNA in lymphoid tissue. These studies suggest that adaptation of SIV to grow in baboon primary cells results in mutations that confer increased replicative capacity in the artificial environment of cell culture but make the virus unable to avoid the restrictive factors generated by a complex multicellular organism.
虽然猴免疫缺陷病毒(SIV)在自然感染的非洲非人灵长类动物宿主中是非致病性的,但实验性或意外感染恒河猴通常会导致艾滋病。狒狒广泛分布于非洲,但它们本身并不携带 SIV,用 SIVmac 感染狒狒只会导致短暂的低水平病毒复制。阐明狒狒天然免疫的机制可以揭示新的抗病毒干预靶点。我们检验了这样一个假设,即适应在狒狒原代细胞中复制的 SIVmac 将获得建立慢性感染的能力。在这里,我们通过在来自不同供体的 PBMC 中(SIVbn-PBMC s1)、在来自同一供体的 PBMC 中(SIVbn-PBMC s2)或在用于系列 2 的同一供体的分离 CD4 细胞中(SIVbn-CD4)对 SIVmac 进行连续传代,在狒狒细胞中产生了 SIVmac 变体。虽然 SIVbn-PBMC s1 和 SIVbn-CD4 显示出增强的复制能力,但 SIVbn-PBMC s2 没有。CCR5 的药理学阻断表明,SIVbn-PBMC s1 比 SIVmac 更有效地利用可用的 CCR5,我们假设这一特性是为了规避趋化因子对受体的占据。序列分析表明,所有三种病毒都积累了不同类型的突变,而且 SIVbn-PBMC s1 中固定的非同义突变比 SIVbn-PBMC s2 和 SIVbn-CD4 更多,这支持了在来自不同遗传背景的 PBMC 中存在更强适应压力的观点。测试几个新固定的 SIV 突变的个体贡献表明,SIVbn-PBMC s1 中这些突变的累加效应导致了其增强的适应性,因为重组单突变病毒在复制能力上与亲本 SIVmac239 株没有差异。通过静脉内感染 SIVbn-PBMC P4 s1 或 SIVmac251,测试了 SIVbn-PBMC 传代 4(P4)s1 的复制能力。虽然感染 SIVmac251 的动物表现出短暂低水平病毒血症的已知模式,但感染 SIVbn-PBMC P4 s1 的动物在淋巴组织中检测不到病毒血症或病毒 DNA。这些研究表明,SIV 适应在狒狒原代细胞中生长导致了在细胞培养的人工环境中增强复制能力的突变,但使病毒无法逃避复杂多细胞生物体产生的限制因素。